XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2019
Sep. 30, 2018
Current Assets:    
Cash and cash equivalents $ 28,916 $ 23,318
Restricted cash   350
Available-for-sale securities 16,070 41,352
Accounts receivable, net of allowance for doubtful accounts of $206 and $147 as of June 30, 2019 and September 30, 2018, respectively 8,381 8,877
Contract assets - royalties and license fees 8,235  
Inventories, net 4,151 4,016
Income tax receivable 560 1,152
Prepaids and other 3,225 2,462
Total Current Assets 69,538 81,527
Deferred tax assets 6,067 6,304
Property and equipment, net 29,559 30,143
Intangible assets, net 15,480 17,683
Goodwill 26,737 27,032
Other assets 2,960 1,446
Total Assets 150,341 164,135
Current Liabilities:    
Accounts payable 2,530 2,546
Accrued liabilities:    
Compensation 2,599 5,635
Accrued other 3,859 6,265
Deferred revenue 5,126 9,646
Contingent consideration 3,113 11,041
Total Current Liabilities 17,227 35,133
Contingent consideration, less current portion   3,425
Deferred revenue, less current portion 9,727 11,247
Other long-term liabilities 4,755 5,720
Total Liabilities 31,709 55,525
Commitments and Contingencies (Note 15)
Stockholders’ Equity:    
Series A Preferred stock- $.05 par value, 450,000 shares authorized; no shares issued and outstanding
Common stock- $.05 par value, 45,000,000 shares authorized; 13,490,323 and 13,397,647 shares issued and outstanding as of June 30, 2019 and September 30, 2018, respectively 675 670
Additional paid-in capital 8,829 7,607
Accumulated other comprehensive income 1,977 2,718
Retained earnings 107,151 97,615
Total Stockholders’ Equity 118,632 108,610
Total Liabilities and Stockholders’ Equity $ 150,341 $ 164,135